Podcast

Illuminating Ovarian Cancer

Author(s):

Kristie L. Kahl

In this episode of CURE Talks Cancer, we caught up with all three storytellers from the “Our Way Forward: Stories that Illuminate the Ovarian Cancer Experience,” storytelling event hosted through a special engagement with The Moth.

Storytelling can help others feel empowered and encourages the narrative around hope for many.

Last month, Tesaro partnered with The Moth, an organization that promotes the art and craft of storytelling, to host a special event called “Our Way Forward: Stories that Illuminate the Ovarian Cancer Experience.”

In this episode of CURE Talks Cancer, we caught up with all three storytellers from the event who shared their experiences with recurrent ovarian cancer.

Related Videos
Dr. Alex Francoeur interviewing against a gray CURE background
Kristie L. Kahl and Dr. Debra Richardson
Related Content
Illustration of a woman with short gray hair, wearing rectangular-framed glasses.
November 19th 2024

My Top 10 List for Living With Cancer

Kelly Irvin
Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of ovaries.
October 30th 2024

Current Treatment May Be Superior to Recentin In Ovarian Cancer

Spencer Feldman
Treatment containing Recentin demonstrated clinical benefits, but it proves worse than the current standard care treatment.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Image of a DNA strand and "Clinical Trial Corner"
October 8th 2024

First Patient With Ovarian Cancer Receives Peptide-Drug Conjugate in Study

Darlene Dobkowski, MA
This trial is assessing CBX-12 as a potential treatment for ovarian cancer, with additional studies to be conducted in other solid tumor types.
Image of Ann Wilson with sister Nancy Wilson - Jamie McCarthy via Getty Images
September 27th 2024

Ann Wilson of Heart Returns After Chemo, Ryan Reynolds Visits Young Patient and More

Alex Biese Ashley Chan
From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.